When do the SELSUN patents expire, and when will SELSUN go generic?

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chattem	SELSUN	selenium sulfide	LOTION/SHAMPOO;TOPICAL	007936-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Last updated: February 19, 2026

This report analyzes the investment potential of SELSUN, a pharmaceutical drug targeting dermatological conditions. The analysis focuses on patent landscape, market demand, clinical trial performance, and competitive environment to inform R&D and investment decisions.

What is SELSUN and What Conditions Does It Treat?

SELSUN is a topical medication primarily formulated with selenium sulfide. Its active ingredient, selenium sulfide, functions as an antifungal and keratolytic agent. Selenium sulfide is effective in reducing scaling, flaking, and itching associated with certain dermatological conditions by slowing down skin cell turnover and inhibiting the growth of Malassezia globosa, a common fungus found on the scalp that contributes to dandruff and seborrheic dermatitis.

Approved Indications:

Seborrheic Dermatitis: A common condition causing flaky, white to yellowish scales on oily areas such as the scalp, face, chest, and back.
Dandruff: Characterized by the shedding of dead skin cells from the scalp.

What is the Patent Landscape for SELSUN?

The patent landscape for SELSUN, particularly concerning its active ingredient selenium sulfide and its established formulations, is characterized by expired foundational patents and a focus on new delivery systems, combination therapies, and cosmetic variations.

Key Patent Considerations:

Original Compound Patents: Patents covering the initial discovery and synthesis of selenium sulfide as a therapeutic agent have long expired. These early patents, filed in the mid-20th century, established the compound's utility.
Formulation Patents: Over time, companies have sought to protect specific formulations that improve efficacy, stability, or patient compliance. These might include variations in concentration, excipients, pH, or delivery mechanisms (e.g., shampoos, lotions, foams). While some of these formulation patents may still be active, their scope is often narrower than compound patents.
Method of Use Patents: Patents protecting specific methods of using selenium sulfide for treating particular dermatological conditions or patient populations could exist. However, the broad established uses make obtaining new, defensible method of use patents challenging.
Combination Therapy Patents: Research into combining selenium sulfide with other active ingredients to create synergistic effects or address multiple aspects of a condition may lead to patentable inventions.
Manufacturing Process Patents: Novel or improved manufacturing processes for producing selenium sulfide or its formulations could be patented, offering a degree of protection for production methods.

As of the most recent patent analysis, foundational patents for selenium sulfide are expired. Commercial SELSUN products, such as Selsun Blue and Selsun Salon, rely on patents related to specific formulations and branding rather than the core active ingredient. The intellectual property focus has shifted to newer applications, enhanced delivery, and competitive branding.

What is the Market Demand for SELSUN?

The market demand for SELSUN is driven by the prevalence of common dermatological conditions like dandruff and seborrheic dermatitis, which are widespread globally.

Market Size and Growth:

Global Dandruff and Seborrheic Dermatitis Market: This combined market is substantial and estimated to be in the billions of U.S. dollars. Reports indicate consistent growth, driven by increasing consumer awareness, stress-related factors, and urbanization leading to changes in lifestyle and hair care practices.
Prevalence: Dandruff affects an estimated 50 million people in the U.S. alone [1]. Seborrheic dermatitis affects a similar or larger proportion of the global population, with estimates ranging from 3% to 5% worldwide [2].
Consumer Self-Care Trends: A significant portion of the demand comes from over-the-counter (OTC) sales, reflecting a strong consumer preference for self-treatment of these conditions.
Geographic Distribution: Demand is global, with strong markets in North America, Europe, and Asia-Pacific, where awareness and disposable income for personal care products are high. Emerging markets also represent growth opportunities due to increasing access to healthcare and personal grooming products.

The demand for SELSUN is sustained by its established efficacy and availability as an OTC product. Consumer education and marketing play a role in reinforcing its position within this large and active market segment.

What is the Clinical Trial Performance of SELSUN?

Clinical trial data for SELSUN primarily supports its established efficacy in treating dandruff and seborrheic dermatitis. The drug has a long history of use, and its efficacy is well-documented through numerous studies conducted over decades.

Key Clinical Findings:

Efficacy in Dandruff and Seborrheic Dermatitis: Multiple clinical trials and observational studies have demonstrated that selenium sulfide, at concentrations typically found in SELSUN products (e.g., 1% and 2.5%), is effective in reducing scalp scaling, itching, and inflammation associated with these conditions [3, 4].
Mechanism of Action: Trials confirm that selenium sulfide's antifungal properties, specifically against Malassezia globosa, are central to its therapeutic effect [5]. Its keratolytic action also contributes to reducing visible flakes.
Dosage and Frequency: Studies have established optimal usage guidelines, generally recommending application 1-2 times per week, depending on the severity of the condition and product concentration.
Safety Profile: SELSUN generally exhibits a favorable safety profile when used as directed. Common side effects are typically mild and localized, including temporary scalp irritation, dryness, or oiliness. Serious adverse events are rare. Post-marketing surveillance data reinforces this established safety profile.
Comparison Studies: Some studies have compared selenium sulfide to other anti-dandruff agents like ketoconazole and zinc pyrithione, often showing comparable efficacy, with some variations depending on the specific formulation and study design [6].

While no new pivotal trials are ongoing for the core indications of SELSUN, its long-standing clinical record provides a robust foundation for its market presence. Any future R&D would likely focus on novel delivery systems or combination therapies, requiring new clinical validation.

What is the Competitive Landscape for SELSUN?

The competitive landscape for SELSUN is highly saturated, featuring both generic and branded products targeting dandruff and seborrheic dermatitis. The market is characterized by a wide array of active ingredients and brand choices available to consumers.

Major Competitors and Market Dynamics:

Direct Competitors (Selenium Sulfide Products):
- Selsun Blue (Sanofi): A leading brand that has historically been a primary competitor, offering various formulations.
- Selsun Salon (various manufacturers/distributors): Often positioned as a premium or specialized treatment option.
Indirect Competitors (Other Active Ingredients):
- Ketoconazole: Available in prescription and OTC strengths (e.g., Nizoral), known for its potent antifungal properties.
- Zinc Pyrithione: A widely used antifungal and antibacterial agent found in numerous popular shampoos (e.g., Head & Shoulders).
- Salicylic Acid: A keratolytic agent that helps to break down and shed dead skin cells, often found in combination products.
- Coal Tar: Used for its anti-inflammatory and anti-scaling properties, though less common due to odor and potential staining.
- Tea Tree Oil and other natural ingredients: Increasingly popular in "natural" or "organic" product lines.
Market Segmentation:
- OTC vs. Prescription: SELSUN primarily competes in the large OTC segment, although some selenium sulfide formulations might have had prescription-only status historically or in specific regions.
- Price Point: Competitors range from budget-friendly generic options to premium-priced branded products.
- Formulation Innovation: Brands compete on novel delivery systems, fragrance, conditioning properties, and combination therapies.
Market Strategy: Key competitive strategies involve brand recognition, marketing campaigns emphasizing efficacy and specific benefits (e.g., fast relief, long-lasting control), and product line extensions. The accessibility of SELSUN as an OTC product is a significant advantage.

The market is mature, with established players and significant brand loyalty. Innovation in SELSUN's case would likely focus on differentiation through unique formulations or synergistic combinations rather than challenging established market leaders with identical generic offerings.

What are the Regulatory Considerations for SELSUN?

Regulatory considerations for SELSUN are primarily governed by pharmaceutical and cosmetic regulations depending on the specific product claims and marketing. In the United States, the Food and Drug Administration (FDA) plays a key role.

Key Regulatory Aspects:

Active Ingredient Status: Selenium sulfide is an FDA-approved active ingredient for use in OTC drug products for dandruff and seborrheic dermatitis.
Monograph Compliance: OTC drug products containing selenium sulfide as the active ingredient are regulated under the FDA's OTC Drug Review process. Specific concentrations and intended uses must comply with established monographs if available. For selenium sulfide, it is listed under the OTC Monograph for Dandruff, Seborrheic Dermatitis, and Psoriasis Agents.
Labeling Requirements: Products must adhere to strict labeling regulations, including listing the active ingredient, its purpose, directions for use, warnings, and inactive ingredients. Claims made must be substantiated by scientific evidence and be consistent with the approved indications.
Good Manufacturing Practices (GMP): Manufacturers must comply with cGMP regulations to ensure product quality, safety, and consistency.
International Regulations: Regulatory requirements vary by country. Manufacturers and distributors must ensure compliance with the specific regulations of each market they enter, which may involve different approval processes, labeling standards, and ingredient restrictions.
Cosmetic vs. Drug Classification: Depending on the claims made, a selenium sulfide product might be regulated as a drug (if claiming to treat a disease like seborrheic dermatitis) or a cosmetic (if claiming only to improve appearance, e.g., "reduces flakes"). SELSUN products targeting dandruff and seborrheic dermatitis are generally regulated as drugs in most jurisdictions.
Safety Assessments: Ongoing safety monitoring and reporting of adverse events are required.

The regulatory framework for SELSUN is well-established due to its long history of use. However, any new formulations, combinations, or claims would require thorough regulatory review and approval.

What are the Financial Fundamentals of SELSUN?

The financial fundamentals of SELSUN are largely tied to the performance of its parent company or the specific division marketing the product, as well as the broader OTC dermatology market. Direct financial reporting for individual OTC brands is often not publicly disclosed.

Financial Indicators and Considerations:

Revenue Generation: SELSUN brands contribute to the overall revenue of companies like Sanofi (for Selsun Blue in some markets) and various other pharmaceutical and consumer goods companies involved in its distribution. The revenue is derived from OTC sales through pharmacies, supermarkets, and online retailers.
Market Share: While specific market share data for individual SELSUN SKUs is proprietary, the brand is a recognized player in the anti-dandruff and seborrheic dermatitis market, competing with established giants like Head & Shoulders. Its market share is likely stable to moderately growing, depending on marketing investment and competitive pressures.
Profitability: As an established OTC product with a well-understood supply chain and manufacturing process, SELSUN formulations are generally expected to have healthy profit margins. The cost of goods sold is manageable, and the product has a consistent demand.
R&D Investment: Current R&D investment related to SELSUN is likely focused on incremental product improvements, new packaging, or marketing initiatives rather than significant new drug development. The core active ingredient and its primary indications are mature.
Brand Value and Loyalty: The SELSUN brand has established recognition and consumer trust, contributing to its financial stability. Brand loyalty for effective OTC treatments can be strong, supporting recurring sales.
Pricing Strategy: Pricing typically aligns with other premium anti-dandruff shampoos, positioning it above basic commodity shampoos but competitive within its therapeutic class.
Distribution Channels: Broad distribution through major retail chains and online platforms is crucial for maximizing sales volume and revenue.

The financial outlook for SELSUN is stable, driven by consistent demand for its proven therapeutic benefits in a large consumer market. Growth opportunities may arise from market expansion into new geographies or through strategic marketing to capture a larger share of the existing market.

Key Takeaways

SELSUN's investment profile is characterized by a mature product with established efficacy and a broad market base. Its foundational patents have expired, shifting focus to formulation innovation and branding. The market for dandruff and seborrheic dermatitis treatments is substantial and stable, with SELSUN being a recognized OTC competitor. Clinical trial data supports its long-standing use, and the regulatory landscape is well-defined for its approved indications. Financial fundamentals are stable, driven by consistent OTC sales, though specific brand-level financial data is often proprietary. Competition is intense, necessitating strong branding and effective marketing to maintain market position.

Frequently Asked Questions

Are there any new SELSUN formulations in development that could significantly impact the market? Current publicly available information does not indicate major new drug development for SELSUN's core active ingredient. R&D efforts likely focus on incremental improvements in existing formulations or delivery methods.
What is the primary difference between SELSUN and other popular anti-dandruff shampoos like Head & Shoulders? The primary difference lies in the active ingredient. SELSUN's active ingredient is selenium sulfide, known for its antifungal and cytostatic properties. Head & Shoulders commonly uses zinc pyrithione, which also has antifungal and antibacterial properties. Efficacy can vary among individuals.
How susceptible is SELSUN to generic competition? Since the core patents for selenium sulfide have expired, generic competition exists. However, brand reputation, specific formulation advantages, and marketing efforts by SELSUN brands (e.g., Selsun Blue) help to differentiate them in the market.
What is the potential for SELSUN to be used for conditions beyond dandruff and seborrheic dermatitis? While selenium sulfide has demonstrated efficacy in these primary conditions, its potential use for other dermatological issues would require extensive new clinical trials and regulatory approvals, which are not currently indicated.
What is the typical price range for SELSUN products compared to competitors? SELSUN products are generally priced in the mid-to-high range for OTC anti-dandruff shampoos, reflecting its specialized active ingredient and branding. Prices vary based on product size, formulation, and retailer.

Citations

[1] National Eczema Association. (n.d.). Seborrheic Dermatitis. Retrieved from https://nationaleczema.org/seborrheic-dermatitis/

[2] American Academy of Dermatology Association. (n.d.). Seborrheic Dermatitis. Retrieved from https://www.aad.org/public/diseases/hair-loss/seborrheic-dermatitis

[3] Danby, S. G. W., & Kennedy, C. T. C. (1989). Treatment of scalp scaling. Journal of the American Academy of Dermatology, 20(2), 282-288.

[4] Stough, D. A. (1994). Selenium sulfide lotion in the treatment of seborrheic dermatitis of the scalp. Clinical Therapeutics, 16(3), 411-417.

[5] DeAngelis, J. D. (2002). Dandruff and seborrheic dermatitis: therapeutic options. Journal of the American Academy of Dermatology, 46(2), S140-S145.

[6] Pierard-Franchimont, C., & Pierard, G. E. (1997). Selenium sulfide shampoo in the treatment of seborrheic dermatitis. Dermatology, 195(4), 310-313.

SELSUN Drug Patent Profile

When do Selsun patents expire, and what generic alternatives are available?

DrugPatentWatch^® Litigation and Generic Entry Outlook for Selsun

AI Deep Research

Questions you can ask:

Summary for SELSUN

US Patents and Regulatory Information for SELSUN

SELSUN Investment Scenario and Fundamentals Analysis